Both organizations would find treatment options for diabetics with 'virtual doctor'.
International Business Machines Corporation has taken an initiative to address the concerns of the healthcare community. The New York based organization’s division IBM Watson Health is collaborating with the Danish pharmaceutical company Novo Nordisk A/S to pioneer a “virtual doctor” for diabetics that can offer treatment advice like insulin dosage.
The Danish diabetes expert expects to utilize the corporation’s supercomputing system, to conduct an analysis of medical data from diabetes patients to let them carry out the management of their illness. IBM news exclaimed that the Jakob Riis, executive vice president at Novo Nordisk, stated information from continuous monitors of blood-sugar levels that are known for uploading readings to the web could be analyzed and utilized to suggest treatment decisions. He stated that more information could possibly be included into such an instrument, including accurate details, exercise and food consumption on the dosage and timings of insulin injections.
There are “a lot of routine issues around judgments of dosing and the whole interplay between food intake, exercise and insulin that could be better handled by AI [artificial intelligence] that can draw on a much broader source of data,” Mr. Riis stated. “That is what computers typically do well.”
IBM news today affirmed that Watson system got popular when it defeated two contestants on the TV show “Jeopardy” in 2011. It is a collection of artificial intelligence application, which could analyze and process massive amounts of data to answer questions and spot patterns.
IBM introduced its Watson Health enterprise previously this year to emphasize on softwares in the medical sector. Novo Nordisk is not the only organization to employ the AI system in the medical field. Amongst the previous adopters was the Memorial Sloan Kettering Cancer center of New York, which stated three years ago that it was collaborating with artificial intelligence system to pioneer a technology to let oncological experts gather massive amounts of clinical information to treat and diagnose cancer.
Other significant hospitals have carried out the same practice in different disease areas, and pharmaceutical companies have succeeded in getting on board. Previously this year, Johnson & Johnson collaborated with IBM to establish a “virtual coach” for people who have undergone knee replacement surgical operation.
IBM Breaking news reported that the collaboration with the European organization would also be spanning other ventures. Mr. Riis stated it would also involve studying the 50 million anonymized American healthcare records kept by the AI system. Those records include a cross section of Americans, not just diabetics, but can be utilized to comprehend what kinds of treatments work well in specific groups and why some sections manage diabetes in a better manner than others do.
He stated the collaboration could also let the pharmaceutical enterprise gather real world information on patients, utilizing its drugs, which in turn can be employed to help it negotiate with payers.
No comments:
Post a Comment